Multiple sclerosis and susceptibility to celiac disease: An osteopontin gene haplotypes affair?

Immunology Letters

Volumn 163, Issue 1, 2015, Pages 132-133

  Mormile, Raffaella ^a  

^a g Moscati Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTEN; INTERLEUKIN 17; OSTEOPONTIN;

CD103+ DENDRITIC CELL; CELIAC DISEASE; CELL HYPERPLASIA; CELL INFILTRATION; DENDRITIC CELL; DISEASE PREDISPOSITION; GENE EXPRESSION; HAPLOTYPE; HUMAN; LETTER; MULTIPLE SCLEROSIS; OPN GENE; PATHOGENESIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH17 CELL; ANIMAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY;

ANIMALS; CELIAC DISEASE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MULTIPLE SCLEROSIS; OSTEOPONTIN;

EID: 84919922134     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.11.015     Document Type: Letter

References (15)

1. Trapp B.D., Nave K.A. Multiple sclerosis: an immune neurodegenerative disorder?. Annu Rev Neurosci 2008, 31:247-269.
2. Chou I.J., Whitehouse W.P., Wang H.S., Tanasescu R., Constantinescu C.S. Diagnostic modalities in multiple sclerosis: perspectives in children. Biomed J 2014, 37(2):50-59.
3. Trager N., Butler J.T., Haque A., Ray S.K., Beeson C., Banik N.L. The involvement of calpain in CD4+ T helper cell bias in multiple sclerosis. J Clin Cell Immunol 2013, 4(4):1000153.
4. Segal B.M. Stage-specific immune dysregulation in multiple sclerosis. J Interferon Cytokine Res 2014, 34(8):633-640.
5. Shimizu Y., Ota K., Ikeguchi R., Kubo S., Kabasawa C., Uchiyama S. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. J Neuroimmunol 2013, 263(1-2):148-151.
6. Comi C., Cappellano G., Chiocchetti A., Orilieri E., Buttini S., Ghezzi L., et al. The impact of osteopontin gene variations on multiple sclerosis development and progression. Clin Dev Immunol 2012, 212893.
7. Shaygannejad V., Ghasemi M., Mirmohamadsadeghi M. Multiple sclerosis or neurological manifestations of celiac disease. Adv Biomed Res 2013, 30(2):38.
8. Caglayan H.Z., Irkec C., Yildirim-Capraz I., Atalay-Akyurek N., Dumlu S. A case of multiple sclerosis and celiac disease. Case Rep Neurol Med 2013, 576921.
9. Azizi Z., Ebrahimi Daryani N., Rezaii Salim M., Javid Anbardan S. A case of concurrent multiple sclerosis and celiac disease. Govaresh 2014, 18(4).
10. Bayardo M., Punzi F., Bondar C., Chopita N., Chirdo F. Transglutaminase 2 expression is enhanced synergistically by interferon-γ and tumour necrosis factor-α in human small intestine. Clin Exp Immunol 2012, 168(1):95-104.
11. Lahdenperä A.I., Fälth-Magnusson K., Högberg L., Ludvigsson J., Vaarala O. Expression pattern of T-helper 17 cell signaling pathway and mucosal inflammation in celiac disease. Scand J Gastroenterol 2014, 49(2):145-156.
12. Neuman M.G. Osteopontin biomarker in inflammatory bowel disease, animal models and target for drug discovery. Dig Dis Sci 2012, 57(6):1430-1431.
13. Kourepini E., Aggelakopoulou M., Alissafi T., Paschalidis N., Simoes D.C. Osteopontin expression by CD103- dendritic cells drives intestinal inflammation. Proc Natl Acad Sci U S A 2014, 111(March (9)):E856-E865.
14. Rescigno M., Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest 2009, 119(9):2441-2445.
15. Cerovic V., Houston S.A., Scott C.L., Aumeunier A., Yrlid U., Mowat A.M., et al. Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells. Mucosal Immunol 2013, 6(January (1)):104-113.